Trials
Search / Trial NCT06431659

Swedish Palliative Care Guide (S-PCG) at Nursing Homes

Launched by REGION SKANE · May 27, 2024

Apply for Trial

Trial Information

Current as of March 14, 2025

Enrolling by invitation

Keywords

Palliative Care Elderly Nursing Homes Dementia

ClinConnect Summary

The study will include six-ten (based on number of patients in every cluster) nursing homes who are interested in implementing the S-PCG part 2. Among the included nursing homes half will be randomized to get help to implement the S-PCG immediately (active group), while the other half will get the same help somewhat later, and act as a control group until then (control group). The process of implementing S-PCG includes education and training in using the Care guide, this training is available physically as well as digitally. The implementation process, including education and training for s...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • - Living at one of the nursing homes that participates in the study and consents to the study or that next of kin consents (in case of excessively impaired cognition).
  • Exclusion criteria:
  • • That the person is dying or too ill to be asked about participation.
  • • That the person is not capable of giving their informed consent (e.g. due to their dementia) and missing relatives.

Trial Officials

Maria Schelin, ass. prof.

Principal Investigator

Region Skåne

About Region Skane

Region Skåne is a leading healthcare authority in Sweden, dedicated to advancing medical research and improving patient care through innovative clinical trials. Committed to fostering collaboration between researchers, healthcare professionals, and patients, Region Skåne aims to enhance the understanding of various health conditions and develop effective treatment strategies. With a focus on ethical standards and patient safety, the organization plays a pivotal role in shaping the future of healthcare in the region and beyond, ensuring that clinical trials are conducted with the highest level of scientific rigor and transparency.

Locations

Stockholm, Region Stockholm, Sweden

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0